The U.S. Preventive Services Task Force (USPSTF) recommends clinicians offer PrEP to individuals who may have a higher chance of getting HIV.

In 2019, the U.S. Preventive Services Task Force (USPSTF) issued a Grade “A” recommendation for PrEP (pre-exposure prophylaxis) medications, strongly recommending clinicians provide PrEP services to eligible patients.

When services and items like prescription medicines receive a Grade A or Grade B recommendation from USPSTF, the Affordable Care Act requires coverage by certain insurance plans^‡ with no cost sharing by individuals for the medicine.

For PrEP medications, under the Affordable Care Act, plans should accommodate individuals for whom a particular PrEP medication (generic or brand name) would be medically appropriate, as determined by the individual’s healthcare provider. In addition, PrEP-related lab tests and other services, such as adherence counseling, may also be covered without cost sharing by certain insurance plans.

To learn more, please visit pleaseprepme.org/paying-prep.^§

^‡All non-grandfathered commercial payers and Medicaid expansion plans.

^§Gilead is not affiliated with PleasePrEPMe.